Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

Benzinga Newsdesk www.benzinga.com Negative 67.5%

Neg 67.5% Neu 0% Pos 0%

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $89 to $81.